Charleroi
Belgium
5
2016-10-06
5
2017-12-12
These are the the leading inventors for applications assigned to Euroscreen S.A.:
Euroscreen S.A. based in Charleroi, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders
#2 | 2015-08-20 ✅ Patent 9,422,299 granted on 2016-08-23Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists
#3 | 2014-09-18 ✅ Patent 9,475,814 granted on 2016-10-25Chiral -acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
#4 | 2013-01-24 ✅ Patent 9,695,120 granted on 2017-07-04Substituted pyrrolidines as G-protein coupled receptor 43 agonists
#5 | 2013-01-24 ✅ Patent 8,871,761 granted on 2014-10-28NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
Also check out Euroscreen S.A.'s (Charleroi, Belgium) applicant profile with 8 patent applications submitted.
6104 ⎘